血管紧张素-(1-7)对腹主动脉缩窄大鼠心肌肥厚和纤维化的影响

摘要/Abstract

摘要： 目的探讨血管紧张素-(1-7)[Ang-(1-7)]对腹主动脉缩窄所诱导的大鼠心肌肥厚和纤维化的影响.方法对8周龄雄性SD大鼠行腹主动脉缩窄术并随机分为假手术组、模型对照组和Ang-(1-7)治疗组,对1d后仍存活者皮下植入微量泵持续静脉输注Ang-(1-7)或生理盐水,Ang-(1-7)组(n=14)输注Ang-(1-7)(25μg·kg^-1·h^-1),假手术组(n=15)及模型对照组(n=12)则输注等量的生理盐水,4周后检测血流动力学参数、血浆和心肌AngⅡ浓度、左心室重量指数、心肌细胞横径和心肌胶原容积分数.结果 (1)模型对照组动脉收缩压、舒张压、心率、左室收缩压(LVSP)、左心室舒张末压、左室内压最大上升速率(+dp/dtmax)均明显高于假手术组(P均<0.01),左室内压最大下降速率(-dp/dtmax)低于假手术组(P<0.01).与模型对照组比较,Ang-(1-7)治疗组LVDEP显著减低(P<0.05),-dp/dtmax升高(P<0.05),而收缩压、舒张压、心率、LVSP及+dp/dtmax在两组间无明显差异.(2)在腹主动脉缩窄术后4周,模型对照组左心室质量、左心室质量指数及心肌细胞横径明显高于假手术组(P<0.01),Ang-(1-7)治疗组上述指标虽高于假手术组,但均明显低于模型对照组(P<0.05).(3)Ang-(1-7)治疗组心肌中小血管周围及心肌间质中胶原沉积虽多于假手术组,但明显少于模型对照组(P<0.05).(4)与假手术组比较,模型对照组和Ang-(1-7)治疗组心肌中AngⅡ浓度均明显增高(P<0.01),但模型对照组和Ang-(1-7)治疗组之间无显著差异(P>0.05);3组间血浆AngⅡ水平无明显差异(P>0.05).结论长期静脉输注Ang(1-7)对腹主动脉缩窄引起的动脉压和心肌血管紧张素Ⅱ水平的升高无影响,但使心肌肥厚和纤维化程度显著减轻,并保护受损的心功能.

Abstract: Background To test the hypothesis that chronic administration of angiotensin-(1-7) attenuates cardiac hypertrophy in rats in vivo.Methods Coarctation of the suprarenal abdominal aorta was performed in 41 8-week-old male Sprague Dawley rats. Twenty-four hours after the operation, osmotic minipumps were surgically implanted subcutaneously in the rats, which were randomly divided into 3 groups, including a sham-operation group (n=15) receiving infusion with normal saline, a suprarenal aortic coarctation group (n=12), and a suprarenal aortic coarctation group (n=14) with Ang-(1-7) treatment at the dose of 25 μg·kg^-1·h^-1. Four weeks later, the systolic and diastolic blood pressures were measured and the left ventricular mass index (LVMI, mg/g) was calculated from the ratio of left ventricular weight to body weight. The concentrations of Ang II in the plasma and myocardium were measured by radioimmunoassay, and myocardial interstitial collagen volume fraction (ICVF) was determined by quantitative morphometry of the sections with Picrosirius red staining using an automated image analyzer.Results Suprarenal abdominal aortic coarctation induced a significant increase in carotid artery systolic and diastolic blood pressure, heart weight, LVMI, ICVF, and the concentration of Ang II in the myocardium (P<0.01). Chronic administration of Ang-(1-7) attenuated the increase in the heart weight, LVMI, ICVF and left ventricular diastolic end pressure (LVEDP) caused by suprarenal abdominal aortic coarctation (P<0.05). Ang-(1-7) also increased the formerly decreased maximum left ventricular pressure reduction rate (-dP/dt_max) (P<0.05), but had no effect on blood pressure and the concentration of Ang II in the myocardium. No difference was noted in plasma concentration of Ang II between the 3 groups.Conclusions Ang-(1-7) attenuates cardiac hypertrophy and fibrosis and preserved the impaired left ventricular function induced by left ventricular pressure-overload in rats. These effects are not associated with the changes in the concentrations of Ang II in the left ventricular myocardium and plasma.

中图分类号:

R331

王立军, 何建桂, 马虹, 蔡乙明, 廖新学, 曾武涛, 柳俊, 王礼春. 血管紧张素-(1-7)对腹主动脉缩窄大鼠心肌肥厚和纤维化的影响[J]. 南方医科大学学报, 2005, 25(05): 481-487.

WANG Li-jun, HE Jian-gui, MA Hong, CAI Yi-ming, LIAO Xin-xue, ZENG Wu-tao, LIU Jun, WANG Li-chun. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats[J]. Journal of Southern Medical University, 2005, 25(05): 481-487.

参考文献

[1] Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat [J]. Cardiovasc Res, 1992, 26(7):671-7.
[2] Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system [J].Circulation, 1991, 83(6):1849-65.
[3] Ikeda Y, Nakamura T, Takano H, et al. Angiotensin Ⅱ-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats [J]. J Lab Clin Med, 2000, 135(4):353-9.
[4] Swynghedauw B. Molecular mechanisms of myocardial remodeling [J]. Physiol Rev, 1999, 79(1): 215-62.
[5] Iyer SN, Chappell MC, Averill DB, et al. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan [J]. Hypertension, 1998, 31(2): 699-705.
[6] Santos RA, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7):an update[J]. Regul Pept, 2000,91(1-3):54-62.
[7] Chappell M C, Tallant E A, Brosnihan KB, et al. Conversion of angiotensin I to angiotensin- (1-7) by thimet oliogopeptidase (E.C.3.4.24.15) in vascular smooth muscle cells [J]. J Vasc Biol Med,1995, 5(2): 129-37.
[8] Welches W R, Brosnihan K B, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11 [J]. Life Sci, 1993, 52(18): 1461-80.
[9] Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase[J]. J Biol Chem, 2002, 277(17): 14838-43.
[10] Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9[J]. Circ Res, 2000, 87(5): E1-9.
[11] Crackower MA, Sarao ROG, Yagil C, et al. Angiotensin-converting enzme 2 is an essential regulator of heart function [J]. Nature 2002,417(6891): 822-8.
[12] Chappell M C, Pirro N T, Sykes A, et al. Metabolism of angiotensin(1-7) by angiotensin-converting enzyme [J]. Hypertension, 1998, 31(1Pt 2): 362-7.
[13] Benter IF, Diz DI, Ferrario CM. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin(1-7)[J]. Hypertension, 1995, 26 (6 Pt 2): 1138-44.
[14] Moriguchi A, Tallant EA, Matsumum K, et al. Opposing actions of angiotensin- (1-7) and angiotensin Ⅱ in the brain oftransgenic hypertensive rats[J]. Hypertension, 1995, 25(6): 1260-5.
[15] 曾武涛,马虹,鲁伟,等.血管紧张素-(1-7)在血管紧张素Ⅱ诱导心肌细胞肥大中的作用[J].中华心血管病杂志,2000,28(6):460-3.Zeng WT, Ma H, Lu W, et al. The role of angiotensin-(1-7) in myocardial cell hypertrophy induced by angiotensin Ⅱ [J]. Chin J Cardiol, 2000, 28(6): 460-3.
[16] 曾武涛,马虹,冷秀玉,等.血管紧张素-(1-7)对血管紧张素Ⅱ诱导心肌细胞原癌基因c-fos表达的影响[J].中国心血管杂志,2003,8(1):9-11.Zeng WT, Ma H, Leng XY, et al. Effects of angiotensin-(1-7) on the expression of proto-oncogene c-fos in cardiomyocyte induced by angiotensin Ⅱ[J]. Chin J Cardiovasc Med, 2003, 8(1): 9-11.
[17] Jouannot P, Hatt P. Rat myocardial mechanics during pressure-induced hypertrophy development and reversal[J]. Am J Physiol, 1975, 229(2): 355-64.
[18] Loot AE, Roks AJ, Henning RH, et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats [J]. Circulation, 2002, 105(13): 1548-50.
[19] Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas [J].Proc Natl Acad Sci U S A, 2003, 100(14): 8258-63.
[20] Takemoto M, Egashira K, Usui M, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats [J]. J Clin Invest,1997, 99(2): 278-87.
[21] Frohlich ED. Risk mechanisms in hypertensive heart disease [J].Hypertension, 1999, 34(4):782-9.
[22] Weber KT. The what, why, and how of hypertensive heart disease [J]. J Hum Hypertens, 1994, 8(9): 665-75.
[23] Weber KT. Angiotensin Ⅱ and connective tissue: homeostasis and reciprocal regulation[J]. Regul Pept, 1999, 82(1-3): 1-17.
[24] Sun Y, Ratajska A, Zhou G, et al. Angiotensin converting enzyme and myocardial fibrosis in rats receiving angiotensin Ⅱ and aldosterone[J]. J Lab Clin Med 1993, 122(4): 395-403.
[25] Levy BI, Michel JB, Salzmann JL, et al. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension[J]. Circ Res, 1988, 63(1):227-39.
[26] Linz W, Schaper J, Wiemer G, et al. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats[J]. Br J Pharmacol, 1992, 107(4): 970-5.
[27] Kobayashi S, Yano M, Kohno M, et al. Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats[J]. Circulation, 1996, 94(12): 3362-8.
[28] Tokuda K, Kai H, Kuwahara F, et al. Pressure-independent effects of angiotensin Ⅱ on hypertensive myocardial fibrosis [J]. Hypertension,2004, 43(2): 499-503.
[29] Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin(1-7) on isolated rabbit afferent arterioles [J]. Hypertension, 2002,39(6): 799-802.
[30] Ferrario CM, Chappell MC. Novel angiotensin peptides [J]. Cell Mol Life Sci, 2004, 61(21): 2720-7.
[31] Luque M, Martin P, Martell N, et al. Effects of captopril related to increased levels ofprostacyclin and angiotensin- (1-7) in essential hypertension[J]. J Hypertens 1996, 14(6): 799-805.
[32] Machado RD, Ferreira MA, Belo AV, et al. Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature [J].Regul Pept, 2002, 107(1-3): 105-13.
[33] Machado RD, Santos RA, Andrade SP. Mechanisms of angiotensin(1-7)-induced inhibition of angiogenesis [J]. Am J Physiol(RICP),2001, 280(4): R994-R1000.
[34] 曾武涛,董吁钢,马虹,等.血管紧张素-(1-7)对血管紧张素Ⅱ诱导培养乳鼠非心肌细胞增殖的影响[J].中山医科大学学报,2001,22(4):241-4Zeng WT, Dong YG, Ma H, et al. The influence of Angiotensin-(1-7) on proliferation of cultured cardiac non-myocytes of neonatal rats induced by angiotensin Ⅱ [J]. Acad J SUMS, 2001, 22 (4):241-4.
[35] Mahon JM, Can RD, Nicol AK, et al. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin Ⅱ receptor [J]. J Hypertens,1994, 12(12): 1377-81.
[36] Ueda S, Masumori-Maemoto S, Ashino K, et al. Angiotensin-(1-7)attenuates vasoconstriction evoked by angiotensin Ⅱ but not by noradrenaline in man [J]. Hypertension, 2000, 35(4): 998-1001.
[37] Roks AJM, van Geel PP, Pinto YM, et al. Angiotensin-(1-7) is a modulator of the human rennin-angiotensin system [J]. Hypertension,1999, 34(2): 296-301.
[38] Strewn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury[J]. Hypertension, 1999,33(1 Pt 2): 207-11.
[39] Santos RA, Ferreira AJ, Nadu AP, et al. Expression of an angiotensin(1-7)-producing fusion protein produces cardioprotective effects in rats[J], Physiol Genomics, 2004, 17(3): 292-9.